Shijiazhuang, China

Kunshen Liu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2014.


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kunshen Liu: Innovator in Diuretic Pharmaceutical Composition

Introduction

Kunshen Liu is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of diuretic compounds. His innovative work has the potential to improve treatment options for patients suffering from heart failure.

Latest Patents

Kunshen Liu holds a patent for "Nitrate esters of corticoid compounds useful as diuretics." This invention relates to the diuretic effects of nitrate esters of corticoid compounds. The patent describes a method for treating patients in heart failure by administering a therapeutically effective dosage of a pharmaceutical composition that includes a nitrate ester of a corticoid compound. The general formula for this compound is B—X—NO. Additionally, the patent outlines a method for improving kidney function through the same therapeutic approach.

Career Highlights

Throughout his career, Kunshen Liu has demonstrated a commitment to advancing medical science. His work on diuretic compounds showcases his expertise in pharmaceutical innovation. Liu's contributions are particularly relevant in the context of treating heart failure, a condition that affects millions of individuals worldwide.

Collaborations

Kunshen Liu has collaborated with notable individuals in his field, including Chao Liu. These partnerships have likely contributed to the development and refinement of his innovative ideas.

Conclusion

Kunshen Liu's work in the field of diuretics represents a significant advancement in pharmaceutical science. His patent for nitrate esters of corticoid compounds highlights his dedication to improving patient care and treatment outcomes. The impact of his innovations may lead to better management of heart failure and related conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…